This inventor holds 2 USPTO granted patents. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: The Innovations of Peng Li
Introduction
Peng Li is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating FXR related diseases. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Peng Li's latest patents include a steroid derivative FXR agonist. This invention relates to a compound represented by formula (I), a tautomer thereof, or a pharmaceutically acceptable salt thereof. It also discusses applications in the preparation of drugs for treating FXR related diseases. This innovative approach showcases his commitment to advancing pharmaceutical science.
Career Highlights
Peng Li is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His role in this esteemed company allows him to further his research and development efforts in the pharmaceutical industry. His contributions are vital in the ongoing quest for effective treatments.
Collaborations
Peng Li has collaborated with notable colleagues such as Haiying He and Hualing Xiao. These partnerships enhance the research environment and foster innovation within their projects.
Conclusion
Peng Li's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect a dedication to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile